Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › TX › Sinton › NPI 1033262936
Clinic

South Texas Family Planning & Health Corporation

South Texas Family Planning & Health Corporation was paid $379K by Medicaid between Jan 2018 and Nov 2024, across 24 billing codes. Its largest line is S4993, Contraceptive pills for birth control — 23% of everything it billed.

33Billing provider infoSOUTH TEXAS FAMILY PLANNING & HEALTH CORPORATION
SINTON, TX 78387
33aNPI1033262936assigned 01/22/2007
28Total paid$379K
24GClaims19,950
24DCodes billed24
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers

Next to other Ambulatory Family Planning Facility providers in Texas

Rank by total paid#20 of 73
Median peer was paid$144K
This provider vs. median2.6×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$5.0K$10K$15K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018103$779.86
20203,373$73K
20215,822$114K
20226,272$121K
20233,917$65K
2024incomplete463$6K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
S4993 Contraceptive pills for birth control 23% 843 810 $86K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 18% 2,553 2,411 $68K
A4267 Contraceptive supply, condom, male, each 16% 4,936 4,546 $61K
J1050 Injection, medroxyprogesterone acetate, 1 mg 15% 775 769 $55K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 13% 825 816 $51K
81025 2.8% 1,588 1,531 $11K
80061 Lipid panel 2.7% 1,447 1,424 $10K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 2.5% 811 782 $10K
83036 Hemoglobin; glycosylated (A1C) 1.8% 1,177 1,154 $7K
G0433 Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening 1.7% 454 442 $6K
A9150 Non-prescription drugs <1% 248 229 $3K
82947 <1% 1,444 1,419 $3K
12 more codes
81003 <1% 1,231 $2K
85018 <1% 730 $1K
99385 <1% 14 $1K
G0475 Hiv antigen/antibody, combination assay, screening <1% 43 $822.40
85014 <1% 426 $777.45
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 40 $737.15
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 28 $707.52
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 28 $707.52
90688 <1% 24 $385.95
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 27 $186.99
87210 <1% 42 $163.32
J3490 Unclassified drugs 0% 216 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialZUNIGA, MARTHA (EXECUTIVE DIRECTOR)
Same official

Other billing entities under ZUNIGA, MARTHA

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.